Protocol of Study 2 from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi,Yaoping Shi,Ahmed O. Kaseb,Xingxing Qi,Yuan Zhang,Jiachang Chi,Qing Lu,Huiping Gao,Hua Jiang,Huamao Wang,Daijing Yuan,Hong Ma,Hongyang Wang,Zonghai Li,Bo Zhai
DOI: https://doi.org/10.1158/1078-0432.22475709
2023-01-01
Abstract:<p>CG1006-CAR-GPC3 T cells clinical trial</p>
What problem does this paper attempt to address?